Last reviewed · How we verify

NCT05584280: SPECS

Systematic Post-Implementation Evaluation of Stents

Recruiting now Last updated 27 April 2023
What this trial tests

trial testing Orsiro stent on shelf in Myocardial Ischemia in 6,000 participants. Currently enrolling.

Timeline
7 December 2022
Primary endpoint
31 December 2025
30 June 2026

Quick facts

Lead sponsorVastra Gotaland Region
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment6,000
Start date7 December 2022
Primary completion31 December 2025
Estimated completion30 June 2026
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Vastra Gotaland Region — full company profile →

Who can join

Eligibility, any sex, with Myocardial Ischemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To conduct a quality assurance project to establish the differences in health care processes and cost effectiveness of having the thin-strut Orsiro stent versus the thicker strut Promus stent on the shelf (i.e. as the most accessible stent).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient data analysis.
    Ryan M, Petrie MC, Kontopantelis E, Dodd M, et al · · 2025 · cited 13× · PMID 40048661 · DOI 10.1093/eurheartj/ehaf080

Verify or expand the search:

Other recruiting trials for Myocardial Ischemia

Currently open trials in the same condition.

Other Vastra Gotaland Region trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05584280.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing